A glucose-responsive insulin therapy protects animals against hypoglycemia

Hypoglycemia is commonly associated with insulin therapy, limiting both its safety and efficacy. The concept of modifying insulin to render its glucose-responsive release from an injection depot (of an insulin complexed exogenously with a recombinant lectin) was proposed approximately 4 decades ago...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCI Insight
Prif Awduron: Yang, Ruojing, Wu, Margaret, Lin, Songnian, Nargund, Ravi P., Li, Xinghai, Kelly, Theresa, Yan, Lin, Dai, Ge, Qian, Ying, Dallas-yang, Qing, Fischer, Paul A., Cui, Yan, Shen, Xiaolan, Huo, Pei, Feng, Danqing Dennis, Erion, Mark D., Kelley, David E., Mu, James
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821182/
https://ncbi.nlm.nih.gov/pubmed/29321379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.97476
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg